Business
AMP German Cannabis Group Commence Trading on the CSE and Announces Investment Policy Focused on the European Medical Cannabis Industry
AMP German Cannabis Group Commence Trading on the CSE and Announces Investment Policy Focu...
About this update from Greenrise Global Brands Inc
[{"type":"text","content":"\n\n\n\nAMP German Cannabis Group Commence Trading on the CSE and Announces Investment Policy Focused on the European Medical Cannabis Industry\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nBERLIN, Sept. 4, 2019\n\n\n\nNew investments will focus on supplying Germany with medical cannabis AMP's lead investment, AMP Germany, plans to become a significant importer of medical cannabis to Germany from Canada AMP Switzerland plans to invest in the Swiss cannabis market BERLIN, Sept. 4, 2019 /CNW/ - AMP German Cannabis Group Inc. (\"AMP\" or the \"Company\") (formerly \"Chinook Tyee Industry Limited\") (CSE: XCX), (FSE: C4T), (ISIN: CA00176G1028) announces the commencement of trading of its common shares on the Canadian Securities Exchange (CSE).  The Company's common shares were delisted from the TSX Venture Exchange at the close of market on September 3, 2019.  The Company also announces that it has updated investment policy to enhance shareholder value from investments in the European medical cannabis industry.\n\n \n \n\n \nSpecifically, the Company invests in businesses that supply the German market with European Union – Good Manufacturing Practices (\"EU-GMP\") certified medical cannabis. The Company's medical cannabis investment portfolio consists of AMP Alternative Medical Products GmbH (\"AMP Germany\"), whose business is to purchase EU-GMP certified medical cannabis from Canada for distribution in Germany, and Alternative Medical Products Switzerland GmbH (\"AMP Switzerland\"), whose business is to develop agreements to supply the German market with cannabis cultivated from Switzerland.\nAMP Germany \nBased in Erfurt, Germany, AMP Germany intends to import EU-GMP certified cannabis into Germany from licensed producers of cannabis by Health Canada (\"Canadian LP\") and sell it to pharmaceutical distributors in Germany who supply pharmacies who are permitted to dispense medical cannabis prescribed by German physicians.\nEU-GMP certification is an internationally recognized system that ensures pharmaceutical goods, including med...